Global cancer surgery: Delivering safe, affordable, and timely cancer surgery

The Lancet Oncology

Volumn 16, Issue 11, 2015, Pages 1193-1224

  Sullivan, Richard ^a   Alatise, Olusegun Isaac ^b   Anderson, Benjamin O ^c,d   Audisio, Riccardo ^e   Autier, Philippe ^f   Aggarwal, Ajay ^a,g,h   Balch, Charles ⁱ   Brennan, Murray F ^j   Dare, Anna ^k,l   D'Cruz, Anil ^m   Eggermont, Alexander M M ^n,o   Fleming, Kenneth ^p,q   Gueye, Serigne Magueye ^r,s   Hagander, Lars ^t   Herrera, Cristian A ^u,v   Holmer, Hampus ^t   Ilbawi, André M ^w,x   Jarnheimer, Anton ^t   Ji, Jia fu ^y,z   Kingham, T Peter ^j   Liberman, Jonathan ^aa   Leather, Andrew J M ^a   Meara, John G ^ab   Mukhopadhyay, Swagoto ^ab   Murthy, Shilpa S ^ac,ad   Omar, Sherif ^ae   Parham, Groesbeck P ^af,ag   Pramesh, C S ^m   Riviello, Robert ^ac   Rodin, Danielle ^l   Santini, Luiz ^ah   Shrikhande, Shailesh V ^m   Shrime, Mark ^ab   Thomas, Robert ^ai   Tsunoda, Audrey T ^aj   van de Velde, Cornelis ^ak   Veronesi, Umberto ^al   Vijaykumar, Dehannathparambil Kottarathil ^am   Watters, David ^an,ao   Wang, Shan ^ap,aq   Wu, Yi Long ^ar,as   Zeiton, Moez ^at,au   Purushotham, Arnie ^a,g   more..

^a KING'S COLLEGE LONDON   (United Kingdom)

^b OBAFEMI AWOLOWO UNIVERSITY TEACHING HOSPITALS COMPLEX   (Nigeria)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e UNIVERSITY OF LIVERPOOL   (United Kingdom)

^f INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

^g GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^h LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

ⁱ UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^j MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^k ST MICHAEL'S HOSPITAL   (Canada)

^l UNIVERSITY OF TORONTO   (Canada)

^m TATA MEMORIAL HOSPITAL   (India)

ⁿ INSTITUT GUSTAVE ROUSSY   (France)

^o UNIVERSITÉ PARIS SACLAY   (France)

^p UNIVERSITY OF OXFORD   (United Kingdom)

^q OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^r UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^s Grand Yoff Hospital   (Senegal)

^t LUND UNIVERSITY   (Sweden)

^u Ministerio de Salud de Chile   (Chile)

^v PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^w UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^x Union for International Cancer Control   (Switzerland)

^y PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^z Chinese Anti Cancer Association   (China)

^aa McCabe Centre for Law and Cancer   (Australia)

^ab BOSTON CHILDREN S HOSPITAL   (United States)

^ac BRIGHAM AND WOMEN S HOSPITAL   (United States)

^ad INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ae CAIRO UNIVERSITY   (Egypt)

^af UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^ag UNIVERSITY OF ZAMBIA   (Zambia)

^ah INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^ai INCA ^*  (Australia)

^aj Barretos Cancer Hospital   (Brazil)

^ak LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^al EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^am AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

^an DEAKIN UNIVERSITY   (Australia)

^ao BARWON HEALTH   (Australia)

^ap PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^aq Chinese College of Surgeons   (China)

^ar GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^as Chinese Society of Therapeutic Radiology and Oncology   (China)

^at Sadeq Institute   (Libyan Arab Jamahiriya)

^au Orthopaedic Training Rotation   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; NARCOTIC ANALGESIC AGENT;

CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER RESEARCH; CANCER SURGERY; CLINICAL STUDY; CLINICAL TRIAL (TOPIC); COMMUNITY CARE; COST EFFECTIVENESS ANALYSIS; GROSS NATIONAL PRODUCT; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HEALTH INSURANCE; HISTOPATHOLOGY; HUMAN; INVESTMENT; PERIOPERATIVE PERIOD; POLITICS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAFETY; SCALE UP; SURGICAL TECHNIQUE; SURGICAL TRAINING; HEALTH; HEALTH CARE DELIVERY; HEALTH SERVICE; NEOPLASMS;

DELIVERY OF HEALTH CARE; GLOBAL HEALTH; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; NEOPLASMS;

EID: 84942586191     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(15)00223-5     Document Type: Review

References (215)

1. Sullivan R Proto-surgery in ancient Egypt. Acta Med (Hradec Kralove) 1998, 41:109-120.
2. Meara JG, Leather AJ, Hagander L, et al. Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Lancet 2015, 386:569-624.
3. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in WHO, (accessed April 14, 2015). http://globocan.iarc.fr/Pages/burden_sel.aspx.
4. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1. 0, cancer incidence and mortality worldwide: IARC CancerBase No. 11 [internet] 2013, International Agency for Research on Cancer, Lyon, France, (accessed April 14, 2015). http://globocan.iarc.fr.
5. Bray F, Jemal A, Grey N, Ferlay J, Forman D Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol 2012, 13:790-801.
6. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988, 319:525-532.
7. Gatta G, Capocaccia R, Sant M, et al. Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut 2000, 47:533-538.
8. Boyle P, Autier P, Adebamowo C, et al. World breast cancer report 2012, International Prevention Research Institute, Lyon.
9. International covenant on economic, social and cultural rights UN Human Rights Office of the High Commissioner for Human Rights, (accessed March 17, 2015). http://www.ohchr.org/EN/ProfessionalInterest/Pages/CESCR.aspx.
10. Convention on the rights of the child UN Human Rights Office of the High Commissioner for Human Rights, (accessed March 19, 2015). http://www.ohchr.org/en/professionalinterest/pages/crc.aspx.
11. Constitution of the World Health Organization 2006, WHO, World Health Organization, Geneva. 45th edition.
12. Single convention on narcotic drugs, 1961: as amended by the 1972 protocol amending the single convention on narcotic drugs, 1961 1972, UN, United Nations, New York.
13. Making the law work better for people affected by cancer: 2013 report 2014, McCabe Centre for Law and Cancer, Cancer Council Victoria, Melbourne.
14. Liberman J Law in cancer control. World Cancer Report 2014 2014, World Health Organization, Geneva. B.W. Stewart, C.P. Wild (Eds.).
15. Atun R, Aydin S, Chakraborty S, et al. Universal health coverage in Turkey: enhancement of equity. Lancet 2013, 382:65-99.
16. Kankeu HT, Saksena P, Xu K, Evans DB The financial burden from non-communicable diseases in low- and middle-income countries: a literature review. Health Res Policy Syst 2013, 11:31.
17. Ilbawi AM, Einterz EM, Nkusu D Obstacles to surgical services in a rural Cameroonian district hospital. World J Surg 2013, 37:1208-1215.
18. Jan S, Kimman M, Peters SA, Woodward M Financial catastrophe, treatment discontinuation and death associated with surgically operable cancer in South-East Asia: Results from the ACTION Study. Surgery 2015, 157:971-982. the ACTION Study Group.
19. Silva TB, Mauad EC, Carvalho AL, Jacobs LA, Shulman LN Difficulties in implementing an organized screening program for breast cancer in Brazil with emphasis on diagnostic methods. Rural Remote Health 2013, 13:2321.
20. Shrime MG, Dare AJ, Alkire BC, O'Neill K, Meara JG Catastrophic expenditure to pay for surgery worldwide: a modelling study. Lancet Glob Health 2015, 3(suppl 2):S38-S44.
21. Van Minh H, Pocock NS, Chaiyakunapruk N, et al. Progress toward universal health coverage in ASEAN. Glob Health Action 2014, 7:25856.
22. Chaker L, Falla A, van der Lee SJ, et al. The global impact of non-communicable diseases on macro-economic productivity: a systematic review. Eur J Epidemiol 2015, 30:357-395.
23. Hanly P, Soerjomataram I, Sharp L Measuring the societal burden of cancer: the cost of lost productivity due to premature cancer-related mortality in Europe. Int J Cancer 2015, 136:E136-E145.
24. Hanly PA, Sharp L The cost of lost productivity due to premature cancer-related mortality: an economic measure of the cancer burden. BMC Cancer 2014, 14:224.
25. John R, Ross H The global economic cost of cancer: a report summary 2014, American Cancer Society, Atlanta.
26. Bradley CJ, Yabroff KR, Dahman B, Feuer EJ, Mariotto A, Brown ML Productivity costs of cancer mortality in the United States: 2000-2020. J Natl Cancer Inst 2008, 100:1763-1770.
27. Luengo-Fernandez R, Leal J, Gray A, Sullivan R Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol 2013, 14:1165-1174.
28. Shrime MG, Bickler SW, Alkire BC, Mock C Global burden of surgical disease: an estimation from the provider perspective. Lancet Glob Health 2015, 3(suppl 2):S8-S9.
29. Alkire BC, Shrime MG, Dare AJ, Vincent JR, Meara JG Global economic consequences of selected surgical diseases: a modelling study. Lancet Glob Health 2015, 3(suppl 2):S21-S27.
30. Jamison DT, Summers LH, Alleyne G, et al. Global health 2035: a world converging within a generation. Lancet 2013, 382:1898-1955.
31. Gospodarowicz M, Trypuc J, Cruz AD, Khader J, Omar S, Knaul F Cancer services and the comprehensive cancer center. 3rd edn. (accessed June 14, 2015). http://dcp-3.org/sites/default/files/chapters/CANCER%20Ch11%20Cancer%20Services.pdf.
32. Schwartländer B, Stover J, Hallett T, et al. Towards an improved investment approach for an effective response to HIV/AIDS. Lancet 2011, 377:2031-2041. the Investment Framework Study Group.
33. Farmer P, Frenk J, Knaul FM, et al. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet 2010, 376:1186-1193.
34. Knaul FM, Frenk J, Shulman L Closing the cancer divide: a blueprint to expand access in low and middle income countries 2011, Harvard Global Equity Initiative, Boston, MA.
35. Stenberg K, Axelson H, Sheehan P, et al. Advancing social and economic development by investing in women's and children's health: a new Global Investment Framework. Lancet 2014, 383:1333-1354. the Study Group for the Global Investment Framework for Women's Children's Health.
36. Rodin D, Jaffray D, Atun R, Knaul FM, Gospodarowicz M The need to expand global access to radiotherapy. Lancet Oncol 2014, 15:378-380. the Global Task Force on Radiotherapy for Cancer Control and the Union for International Cancer Control.
37. Federspiel F, Mukhopadhyay S, Milsom P, Scott JW, Riesel JN, Meara JG Global surgical and anaesthetic task shifting: a systematic literature review and survey. Lancet 2015, 385(S46). poster 49.
38. Barbash GI, Glied SA New technology and health care costs-the case of robot-assisted surgery. N Engl J Med 2010, 363:701-704.
39. Bolenz C, Gupta A, Hotze T, et al. Cost comparison of robotic, laparoscopic, and open radical prostatectomy for prostate cancer. Eur Urol 2010, 57:453-458.
40. Cancer control opportunities in low- and middle-income countries 2007, National Academies Press (US), Washington, DC. Institute of Medicine Committee on Cancer Control in Low- and Middle-Income Countries, F.A. Sloan, H. Gelband (Eds.).
41. Meara JG, Leather AJ, Hagander L, et al. Global Surgery 2030: Evidence and solutions for achieving health, welfare, and economic development. Surgery 2015, 158:3-6.
42. Ara R, Basarir H, Keetharuth AD, et al. Are policy decisions on surgical procedures informed by robust economic evidence? A systematic review. Int J Technol Assess Health Care 2014, 30:381-393.
43. Dare AJ, Anderson BO, Sullivan R, et al. Surgical services for cancer care. Cancer volume, disease control priorities in developing countries 2015, World Bank, Washington, DC, (accessed Aug 3, 2015). http://dcp-3.org/chapter/1536/surgical-services-cancer-care, 3rd edn. H. Gelband, P. Jha, R. Sankaranarayanan, S. Horton (Eds.).
44. Purushotham AD, Lewison G, Sullivan R The state of research and development in global cancer surgery. Ann Surg 2012, 255:427-432.
45. Campbell JD, Ramsey SD The costs of treating breast cancer in the US: a synthesis of published evidence. Pharmacoeconomics 2009, 27:199-209.
46. Uyl-de-Groot CA, de Vries EGE, Verweij J, Sullivan R Dispelling the myths around cancer care delivery: it's not all about costs. J Cancer Policy 2014, 2:22-29.
47. Health IMS Developments in cancer treatments, market dynamics, patient access and value: global oncology trend report 2015, IMS Institute for Healthcare Informatics, Parsippany, NJ.
48. Kruk ME Universal health coverage: a policy whose time has come. BMJ 2013, 347:f6360.
49. Thorat MA, Rangole A, Nadkarni MS, Parmar V, Badwe RA Revision surgery for breast cancer: single-institution experience. Cancer 2008, 113(suppl):2347-2352.
50. Essential Surgery DCP3, (accessed May 18, 2015). http://dcp-3.org/node/34.
51. Hanvoravongchai P UNICO Study Series 20: health financing reform in Thailand: toward universal coverage under fiscal constraints 2013, The World Bank, Washington, DC.
52. Knaul FM, González-Pier E, Gómez-Dantés O, et al. The quest for universal health coverage: achieving social protection for all in Mexico. Lancet 2012, 380:1259-1279.
53. Yamabhai I, Mohara A, Tantivess S, Chaisiri K, Teerawattananon Y Government use licenses in Thailand: an assessment of the health and economic impacts. Global Health 2011, 7:28.
54. Tantivess S, Teerawattananon Y, Mills A Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program. Pharmacoeconomics 2009, 27:931-945.
55. Tangcharoensathien V, Limwattananon S, Patcharanarumol W, Thammatacharee J, Jongudomsuk P, Sirilak S Achieving universal health coverage goals in Thailand: the vital role of strategic purchasing. Health Policy Plan 2014, published online Sept 30. 10.1093/heapol/czu120.
56. Chalkidou K, Marquez P, Dhillon PK, et al. Evidence-informed frameworks for cost-effective cancer care and prevention in low, middle, and high-income countries. Lancet Oncol 2014, 15:e119-e131.
57. Meropol NJ, Schrag D, Smith TJ, et al. American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol 2009, 27:3868-3874. the American Society of Clinical Oncology.
58. Vasan A, Hudelson CE, Greenberg SL, Ellner AE An integrated approach to surgery and primary care systems strengthening in low- and middle-income countries: building a platform to deliver across the spectrum of disease. Surgery 2015, 157:965-970.
59. Price AJ, Ndom P, Atenguena E, Mambou Nouemssi JP, Ryder RW Cancer care challenges in developing countries. Cancer 2012, 118:3627-3635.
60. Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 2015, 385:977-1010. the CONCORD Working Group.
61. Morhason-Bello IO, Odedina F, Rebbeck TR, et al. Challenges and opportunities in cancer control in Africa: a perspective from the African Organisation for Research and Training in Cancer. Lancet Oncol 2013, 14:e142-e151.
62. Rubin G, Berendsen A, Crawford SM, et al. The expanding role of primary care in cancer control. Lancet Oncol (in press).
63. Neal RD, Tharmanathan P, France B, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer 2015, 112(suppl 1):S92-107.
64. Lyratzopoulos G, Saunders CL, Abel GA, et al. The relative length of the patient and the primary care interval in patients with 28 common and rarer cancers. Br J Cancer 2015, 112(suppl 1):S35-S40.
65. Kingham TP, Alatise OI, Vanderpuye V, et al. Treatment of cancer in sub-Saharan Africa. Lancet Oncol 2013, 14:e158-e167.
66. Smith-Bindman R, Miglioretti DL, Larson EB Rising use of diagnostic medical imaging in a large integrated health system. Health Aff (Millwood) 2008, 27:1491-1502.
67. Baker LC, Atlas SW, Afendulis CC Expanded use of imaging technology and the challenge of measuring value. Health Aff (Millwood) 2008, 27:1467-1478.
68. Shyyan R, Masood S, Badwe RA, et al. Breast cancer in limited-resource countries: diagnosis and pathology. Breast J 2006, 12(suppl 1):S27-S37. the Global Summit Diagnosis and Pathology Panel.
69. Shyyan R, Sener SF, Anderson BO, et al. Guideline implementation for breast healthcare in low- and middle-income countries: diagnosis resource allocation. Cancer 2008, 113(suppl):2257-2268. the Breast Health Global Initiative Diagnosis Panel.
70. Soofi Y, Khoury T Inter-institutional pathology consultation: the importance of breast pathology subspecialization in a setting of tertiary cancer center. Breast J 2015, 21:337-344.
71. Mpunga T, Tapela N, Hedt-Gauthier BL, et al. Diagnosis of cancer in rural Rwanda: early outcomes of a phased approach to implement anatomic pathology services in resource-limited settings. Am J Clin Pathol 2014, 142:541-545.
72. Badve SS, Baehner FL, Gray RP, et al. Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory. J Clin Oncol 2008, 26:2473-2481.
73. Ljung BM, Drejet A, Chiampi N, et al. Diagnostic accuracy of fine-needle aspiration biopsy is determined by physician training in sampling technique. Cancer 2001, 93:263-268.
74. Akarolo-Anthony SN, Ogundiran TO, Adebamowo CA Emerging breast cancer epidemic: evidence from Africa. Breast Cancer Res 2010, 12(suppl 4):S8.
75. Adesina A, Chumba D, Nelson AM, et al. Improvement of pathology in sub-Saharan Africa. Lancet Oncol 2013, 14:e152-e157.
76. Global atlas of palliative care at the end of life 2014, World Health Organization, Geneva. S.R. Connor, M.C.S. Bermedo (Eds.).
77. Kwok AC, Semel ME, Lipsitz SR, et al. The intensity and variation of surgical care at the end of life: a retrospective cohort study. Lancet 2011, 378:1408-1413.
78. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001, 345:638-646. the Dutch Colorectal Cancer Group.
79. Songun I, Putter H, Kranenbarg EM-K, Sasako M, van de Velde CJ Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 2010, 11:439-449.
80. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002, 346:1128-1137.
81. Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL Surgeon volume and operative mortality in the United States. N Engl J Med 2003, 349:2117-2127.
82. von Meyenfeldt EM, Gooiker GA, van Gijn W, et al. The relationship between volume or surgeon specialty and outcome in the surgical treatment of lung cancer: a systematic review and meta-analysis. J Thorac Oncol 2012, 7:1170-1178.
83. Bilimoria KY, Phillips JD, Rock CE, Hayman A, Prystowsky JB, Bentrem DJ Effect of surgeon training, specialization, and experience on outcomes for cancer surgery: a systematic review of the literature. Ann Surg Oncol 2009, 16:1799-1808.
84. Wibe A, Møller B, Norstein J, et al. A national strategic change in treatment policy for rectal cancer-implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 2002, 45:857-866. the Norwegian Rectal Cancer Group.
85. Harling H, Bülow S, Kronborg O, Møller LN, Jørgensen T Survival of rectal cancer patients in Denmark during 1994-99. Colorectal Dis 2004, 6:153-157. the Danish Colorectal Cancer Group.
86. Birgisson H, Talbäck M, Gunnarsson U, Påhlman L, Glimelius B Improved survival in cancer of the colon and rectum in Sweden. Eur J Surg Oncol 2005, 31:845-853.
87. Påhlman L, Bohe M, Cedermark B, et al. The Swedish rectal cancer registry. Br J Surg 2007, 94:1285-1292.
88. Mroczkowski P, Kube R, Schmidt U, Gastinger I, Lippert H Quality assessment of colorectal cancer care: an international online model. Colorectal Dis 2011, 13:890-895.
89. Penninckx F, Van Eycken L, Michiels G, et al. Survival of rectal cancer patients in Belgium 1997-98 and the potential benefit of a national project. Acta Chir Belg 2006, 106:149-157. the PROCARE working group.
90. Van Leersum NJ, Snijders HS, Henneman D, et al. The Dutch surgical colorectal audit. Eur J Surg Oncol 2013, 39:1063-1070.
91. National bowel cancer audit report Health & Social Care Information Centre, (accessed June 3, 2015). http://www.hscic.gov.uk/catalogue/PUB16021.
92. Ortiz H Informe sobre el análisis de resultados y propuestas de mejora del proyecto: "Equipos seguros en la cirugía del cáncer de recto en España" 2009, Ministerio de Sanidad, Política Social e Igualdad Centro de Publicaciones, Madrid.
93. Breugom AJ, Boelens PG, van den Broek CB, et al. Quality assurance in the treatment of colorectal cancer: the EURECCA initiative. Ann Oncol 2014, 25:1485-1492.
94. van de Velde CJ, Aristei C, Boelens PG, et al. EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe. Eur J Cancer 2013, 49:2784-2790. the European Registration of Cancer Care.
95. Urquhart R, Grunfeld E, Jackson L, Sargeant J, Porter GA Cross-disciplinary research in cancer: an opportunity to narrow the knowledge-practice gap. Curr Oncol 2013, 20:e512-e521.
96. Khuri SF, Henderson WG The case against volume as a measure of quality of surgical care. World J Surg 2005, 29:1222-1229.
97. Temple WJ, Francis WP, Tamano E, Dabbs K, Mack LA, Fields A Synoptic surgical reporting for breast cancer surgery: an innovation in knowledge translation. Am J Surg 2010, 199:770-775. the Cancer Surgery Alberta.
98. Brennan MF, Radzyner M, Rubin DM Outcome-more than just operative mortality. J Surg Oncol 2009, 99:470-477.
99. Bleyer A, Welch HG Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012, 367:1998-2005.
100. Houssami N, Turner R, Macaskill P, et al. An individual person data meta-analysis of preoperative magnetic resonance imaging and breast cancer recurrence. J Clin Oncol 2014, 32:392-401.
101. Strother RM, Asirwa FC, Busakhala NB, et al. AMPATH-Oncology: a model for comprehensive cancer care in sub-Saharan Africa. J Cancer Policy 2013, 1:e42-e48.
102. Echavarria MI, Anderson BO, Duggan C, Thompson B Global uptake of BHGI guidelines for breast cancer. Lancet Oncol 2014, 15:1421-1423.
103. Zeng H, Zheng R, Guo Y, et al. Cancer survival in China, 2003-2005: a population-based study. Int J Cancer 2015, 136:1921-1930.
104. Chen W, Zheng R, Zeng H, Zhang S, He J Annual report on status of cancer in China, 2011. Chin J Cancer Res 2015, 27:2-12.
105. Jun W Atlas of video-assisted thoracoscopic lobectomy 2013, People's Health Publishing House, Beijing.
106. Garfield DH, Brenner H, Lu L Practicing western oncology in Shanghai, China: one group's experience. J Oncol Pract 2013, 9:e141-e144.
107. Pramesh CS, Badwe RA, Borthakur BB, et al. Delivery of affordable and equitable cancer care in India. Lancet Oncol 2014, 15:e223-e233.
108. Atomic Energy Regulatory Board Government of India, (accessed Aug 20, 2015). http://dae.nic.in/.
109. Barreto SG, Chaubal GN, Talole S, et al. Rectal cancer in young Indians-are these cancers different compared to their older counterparts?. Indian J Gastroenterol 2014, 33:146-150.
110. Kumar A, Gupta NP, Hemal AK A single institution experience of 141 cases of laparoscopic radical nephrectomy with cost-reductive measures. J Endourol 2009, 23:445-449.
111. Are C, Colburn L, Rajaram S, Vijayakumar M Disparities in cancer care between the United States of America and India and opportunities for surgeons to lead. J Surg Oncol 2010, 102:100-105.
112. Mallath MK, Taylor DG, Badwe RA, et al. The growing burden of cancer in India: epidemiology and social context. Lancet Oncol 2014, 15:e205-e212.
113. Verma Y, Pradhan PK, Gurung N, et al. Population-based cancer incidence in Sikkim, India: report on ethnic variation. Br J Cancer 2012, 106:962-965.
114. Misra S, Chaturvedi A, Misra NC, Sharma ID Carcinoma of the gallbladder. Lancet Oncol 2003, 4:167-176.
115. Shrikhande SV, Sirohi B, Barreto SG, et al. Indian Council of Medical Research consensus document for the management of gastric cancer. Indian J Med Paediatr Oncol 2014, 35:239-243.
116. Sirohi B, Shrikhande SV, Perakath B, et al. Indian Council of Medical Research consensus document for the management of colorectal cancer. Indian J Med Paediatr Oncol 2014, 35:192-196.
117. Projeção da População no Brasil por Sexo e Idade-1980-2050 2008, Instituto Brasileiro de Geografia e Estatística, IBGE, Rio de Janeiro.
118. Relatório De Auditoria Operacional-Política Nacional de Atenção Oncológica 2012, INCA, Rio de Janeiro.
119. Sistema de Informacao Hospitalar Decentralizado (SIHD) 2015, Ministry of Heath, Rio de Janeiro.
120. LEI No 9.797, DE 6 DE MAIO DE 1999. Brazil Presidência da República Casa Civil Subchefia para Assuntos Jurídicos, (accessed June 17, 2015). http://www.planalto.gov.br/ccivil_03/leis/L9797.htm.
121. Ihse I The volume-outcome relationship in cancer surgery: a hard sell. Ann Surg 2003, 238:777-781.
122. Govaert JA, Fiocco M, van Dijk WA, et al. Costs of complications after colorectal cancer surgery in the Netherlands: building the business case for hospitals. Eur J Surg Oncol 2015, 41:1059-1067. the Dutch Value Based Healthcare Study Group.
123. Nathan H, Atoria CL, Bach PB, Elkin EB Hospital volume, complications, and cost of cancer surgery in the elderly. J Clin Oncol 2015, 33:107-114.
124. Lucas DJ, Pawlik TM Quality improvement in gastrointestinal surgical oncology with American College of Surgeons National Surgical Quality Improvement Program. Surgery 2014, 155:593-601.
125. Stitzenberg KB, Sigurdson ER, Egleston BL, Starkey RB, Meropol NJ Centralization of cancer surgery: implications for patient access to optimal care. J Clin Oncol 2009, 27:4671-4678.
126. Yun YH, Kim YA, Min YH, et al. The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery. Ann Oncol 2012, 23:2731-2737.
127. Dickens C, Joffe M, Jacobson J, et al. Stage at breast cancer diagnosis and distance from diagnostic hospital in a periurban setting: a South African public hospital case series of over 1,000 women. Int J Cancer 2014, 135:2173-2182.
128. Gonzaga MA How accurate is ultrasound in evaluating palpable breast masses?. Pan Afr Med J 2010, 7:1-8.
129. Sullivan R, Kowalczyk JR, Agarwal B, et al. New policies to address the global burden of childhood cancers. Lancet Oncol 2013, 14:e125-e135.
130. Mostert S, Arora RS, Arreola M, et al. Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group. Lancet Oncol 2011, 12:719-720.
131. Kliegman RM Nelson textbook of pediatrics 2012, Saunders Elsevier, Amsterdam.
132. Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med 2007, 356:1835-1841.
133. Lilleyman J Simple deliverable therapy needed for childhood leukaemia. Lancet 2003, 362:676-677.
134. Price R, Sergelen O, Unursaikhan C Improving surgical care in Mongolia: a model for sustainable development. World J Surg 2013, 37:1492-1499.
135. Henry JA, Orgoi S, Govind S, Price RR, Lundeg G, Kehrer B Strengthening surgical services at the soum (first-referral) hospital: the WHO emergency and essential surgical care (EESC) program in Mongolia. World J Surg 2012, 36:2359-2370.
136. Parham GP, Mwanahamuntu MH, Kapambwe S, et al. Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia. PLoS One 2015, 10:e0122169.
137. Elit LM, Rosen B, Jimenez W, et al. Teaching cervical cancer surgery in low- or middle-resource countries. Int J Gynecol Cancer 2010, 20:1604-1608. the International Community of Practice Committee of the Society of Gynecologic Oncology of Canada.
138. Mahapatra AK, Mishra SK, Kapoor L, Singh IP Critical issues in medical education and the implications for telemedicine technology. Telemed J E Health 2009, 15:592-596.
139. Are C, Are M, Raj H, Manavalan V, Colburn L, Stoddard H A survey of the educational environment for oncologists as perceived by surgical oncology professionals in India. World J Surg Oncol 2012, 10:18.
140. Kolkman P, Soliman M, Kolkman M, et al. Comparison of resident operative case logs during a surgical oncology rotation in the United States and an international rotation in India. Indian J Surg Oncol 2015, 6:36-40.
141. Badwe RA, Pramesh CS Surgical oncology-at the crossroads. Indian J Surg 2009, 71:290-291.
142. Brennan M The role of U.S. cancer centers in global cancer care. Ann Surg Oncol 2015, 22:747-749.
143. Qureshi JS, Young S, Muyco AP, et al. Addressing Malawi's surgical workforce crisis: a sustainable paradigm for training and collaboration in Africa. Surgery 2013, 153:272-281.
144. Thaddeus S, Maine D Too far to walk: maternal mortality in context. Soc Sci Med 1994, 38:1091-1110.
145. Anderson BO, Cazap E, El Saghir NS, et al. Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. Lancet Oncol 2011, 12:387-398.
146. Koh WJ, Greer BE, Abu-Rustum NR, et al. Cervical cancer. J Natl Compr Canc Netw 2013, 11:320-343. the National Comprehensive Cancer Network.
147. Osman M The role of neoadjuvant chemotherapy in the management of locally advanced cervix cancer: a systematic review. Oncol Rev 2014, 8:250.
148. Mauri D, Pavlidis N, Ioannidis JP Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. J Natl Cancer Inst 2005, 97:188-194.
149. Kehoe S, Hook J, Nankivell M, et al. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial. Lancet 2015, 386:249-257.
150. Rabkin M, El-Sadr WM Ebola: the real lessons from HIV scale-up. Lancet Infect Dis 2015, 15:506.
151. Autry AM, Knight S, Lester F, et al. Teaching surgical skills using video internet communication in a resource-limited setting. Obstet Gynecol 2013, 122:127-131.
152. Chu KM, Ford NP, Trelles M Providing surgical care in Somalia: a model of task shifting. Confl Health 2011, 5:12.
153. Parham GP, Mwanahamuntu MH, Pfaendler KS, et al. eC3-a modern telecommunications matrix for cervical cancer prevention in Zambia. J Low Genit Tract Dis 2010, 14:167-173.
154. Haynes AB, Weiser TG, Berry WR, et al. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med 2009, 360:491-499. the Safe Surgery Saves Lives Study Group.
155. Sullivan R, Eckhouse S, Lewison G Using bibliometrics to inform cancer research policy and spending. Monitoring financial flows for health research 2007 2007, 67-78. Council on Health Research for Development (COHRED), Geneva. M.A. Burke, A. de Francisco, S. Matlin (Eds.).
156. Ciardiello F, Arnold D, Casali PG, et al. Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO). Ann Oncol 2014, 25:1673-1678.
157. McLeod HL Cancer pharmacogenomics: early promise, but concerted effort needed. Science 2013, 339:1563-1566.
158. Makino T, Shukla PJ, Rubino F, Milsom JW The impact of obesity on perioperative outcomes after laparoscopic colorectal resection. Ann Surg 2012, 255:228-236.
159. Stage JG, Schulze S, Møller P, et al. Prospective randomized study of laparoscopic versus open colonic resection for adenocarcinoma. Br J Surg 1997, 84:391-396.
160. Schwenk W, Böhm B, Haase O, Junghans T, Müller JM Laparoscopic versus conventional colorectal resection: a prospective randomised study of postoperative ileus and early postoperative feeding. Langenbecks Arch Surg 1998, 383:49-55.
161. Reza MM, Blasco JA, Andradas E, Cantero R, Mayol J Systematic review of laparoscopic versus open surgery for colorectal cancer. Br J Surg 2006, 93:921-928.
162. Rosenthal EL, Warram JM, Bland KI, Zinn KR The status of contemporary image-guided modalities in oncologic surgery. Ann Surg 2015, 261:46-55.
163. Diana M, Marescaux J Robotic surgery. Br J Surg 2015, 102:e15-e28.
164. Shaw RJ, Hall GL, Woolgar JA, et al. Quantitative methylation analysis of resection margins and lymph nodes in oral squamous cell carcinoma. Br J Oral Maxillofac Surg 2007, 45:617-622.
165. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003, 349:546-553.
166. Purushotham AD, Upponi S, Klevesath MB, et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 2005, 23:4312-4321.
167. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 2006, 98:599-609.
168. Fleissig A, Fallowfield LJ, Langridge CI, et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 2006, 95:279-293.
169. Zavagno G, De Salvo GL, Scalco G, et al. A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg 2008, 247:207-213. the GIVOM Trialists.
170. Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 2007, 8:881-888. the National Surgical Adjuvant Breast and Bowel Project.
171. Wetzig N, Gill PG, Zannino D, et al. Sentinel lymph node based management or routine axillary clearance? Three-year outcomes of the RACS sentinel node biopsy versus axillary clearance (SNAC) 1 trial. Ann Surg Oncol 2015, 22:17-23.
172. Veronesi U, Viale G, Paganelli G, et al. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg 2010, 251:595-600.
173. Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol 2014, 15:1303-1310.
174. Kuehn T, Bauerfeind I, Fehm T, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol 2013, 14:609-618.
175. Boughey JC, Suman VJ, Mittendorf EA, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA 2013, 310:1455-1461. the Alliance for Clinical Trials in Oncology.
176. Nissan A, Protic M, Bilchik AJ, Howard RS, Peoples GE, Stojadinovic A United States Military Cancer Institute Clinical Trials Group (USMCI GI-01) randomized controlled trial comparing targeted nodal assessment and ultrastaging with standard pathological evaluation for colon cancer. Ann Surg 2012, 256:412-427. the United States Military Cancer Institute Clinical Trials Group.
177. Sullivan R, Badwe RA, Rath GK, et al. Cancer research in India: national priorities, global results. Lancet Oncol 2014, 15:e213-e222.
178. Shastri SS, Mittra I, Mishra GA, et al. Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India. J Natl Cancer Inst 2014, 106:dju009.
179. Patil VM, Noronha V, Joshi A, et al. A prospective randomized phase II study comparing metronomic chemotherapy with chemotherapy (single agent cisplatin), in patients with metastatic, relapsed or inoperable squamous cell carcinoma of head and neck. Oral Oncol 2015, 51:279-286.
180. Eckhouse S, Lewison G, Sullivan R Trends in the global funding and activity of cancer research. Mol Oncol 2008, 2:20-32.
181. Cambrosio A, Keating P, Mercier S, Lewison G, Mogoutov A Mapping the emergence and development of translational cancer research. Eur J Cancer 2006, 42:3140-3148.
182. Weiser TG, Regenbogen SE, Thompson KD, et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 2008, 372:139-144.
183. Huang GJ, Mao YS, Zhang DC, Sun KL, He J, Cheng GY Current status and future directions of surgery for lung cancer in China. Chin Med J (Engl) 2007, 120:619-621.
184. Burstein P Policy domains: organization, culture, and policy outcomes. Annu Rev Sociol 1991, 17:327-350.
185. González Block MA The state of international collaboration for health systems research: what do publications tell?. Health Res Policy Syst 2006, 4:7.
186. Eckhouse S, Sullivan R The state of academic cancer surgery in the UK. Mol Oncol 2008, 2:206-212.
187. Stuckler D, King L, Robinson H, McKee M WHO's budgetary allocations and burden of disease: a comparative analysis. Lancet 2008, 372:1563-1569.
188. Gouveia J, Coleman MP, Haward R, et al. Improving cancer control in the European Union: conclusions from the Lisbon round-table under the Portuguese EU Presidency, 2007. Eur J Cancer 2008, 44:1457-1462.
189. Hitt E The flat-funding years and the National Cancer Institute: consequences for cancer research. Mol Oncol 2008, 2:290-292.
190. Shawar YR, Shiffman J, Spiegel DA Generation of political priority for global surgery: a qualitative policy analysis. Lancet Glob Health 2015, 3:e487-e495.
191. Reich MR The politics of agenda setting in international health: child health versus adult health in developing countries. J Int Dev 1995, 7:489-502.
192. Strengthening emergency and essential surgical care and anaesthesia as a component of universal health coverage. 68th World Health Assembly 2015, WHO, World Health Organization, Geneva.
193. Shulman LN, Mpunga T, Tapela N, Wagner CM, Fadelu T, Binagwaho A Bringing cancer care to the poor: experiences from Rwanda. Nat Rev Cancer 2014, 14:815-821.
194. McIntyre P Rising to the challenge in the developing world. Cancer World 2005, May-June:44-48.
195. Wade N Congress looks harder at cancer. Science 1976, 191:364.
196. Harvey JA, Strahilevitz MA The power of pink: cause-related marketing and the impact on breast cancer. J Am Coll Radiol 2009, 6:26-32.
197. King S Pink ribbons, inc.: breast cancer and the politics of philanthropy 2006, University of Minnesota Press, Minneapolis.
198. Ooms G, Van Damme W, Baker BK, Zeitz P, Schrecker T The 'diagonal' approach to Global Fund financing: a cure for the broader malaise of health systems?. Global Health 2008, 4:6.
199. Brown GW, Yamey G, Wamala SP The health systems agenda: prospects for the diagonal approach. The handbook of global health policy 2014, 34-67. John Wiley & Sons Inc., Chichester, UK. G.W. Brown, G. Yamey, S. Wamala (Eds.).
200. Farmer PE, Kim JY Surgery and global health: a view from beyond the OR. World J Surg 2008, 32:533-536.
201. Ozgediz D, Jamison D, Cherian M, McQueen K The burden of surgical conditions and access to surgical care in low- and middle-income countries. Bull World Health Organ 2008, 86:646-647.
202. Hedges JP, Mock CN, Cherian MN The political economy of emergency and essential surgery in global health. World J Surg 2010, 34:2003-2006.
203. Stewart BW, Wild C World cancer report 2014 2014, World Health Organization, Geneva.
204. Rajaram S, Malik R, Agarwal S, Suneja A The role of hospital-based cancer registries in low and middle income countries-Indian statistics. Cancer Epidemiol 2013, 37:e7.
205. Jedy-Agba EE, Curado MP, Oga E, et al. The role of hospital-based cancer registries in low and middle income countries-The Nigerian Case Study. Cancer Epidemiol 2012, 36:430-435.
206. Bhopal SS, Mann KD, Pearce MS Registration of cancer in girls remains lower than expected in countries with low/middle incomes and low female education rates. Br J Cancer 2012, 107:183-188.
207. Kingham TP, Alatise OI Establishing translational and clinical cancer research collaborations between high- and low-income countries. Ann Surg Oncol 2015, 22:741-746.
208. Sullivan R, Purushotham AD Avoiding the zero sum game in global cancer policy: beyond 2011 UN high level summit. Eur J Cancer 2011, 47:2375-2380.
209. Cancer prevention and control WHA58.22. 58th World Health Assembly WHO, (accessed June 14, 2015). http://www.who.int/cancer/media/news/WHA58%2022-en.pdf.
210. Political declaration of the high-level meeting of the general assembly on the prevention and control of non-communicable diseases. General Assembly 66th Session UN, (accessed June 14, 2015). http://www.un.org/ga/search/view_doc.asp?symbol=A/66/L.1.
211. Atun R, Weil DE, Eang MT, Mwakyusa D Health-system strengthening and tuberculosis control. Lancet 2010, 375:2169-2178.
212. Murray CJ, Frenk J A framework for assessing the performance of health systems. Bull World Health Organ 2000, 78:717-731.
213. Annan K Partnerships for global community: annual report on the work of the organization 1998, United Nations, New York.
214. Stulac S, Binagwaho A, Tapela NM, et al. Capacity building for oncology programmes in sub-Saharan Africa: the Rwanda experience. Lancet Oncol 2015, 16:e405-e413.
215. Hart JT The inverse care law. Lancet 1971, 1:405-412.